Unlike the pretreatment MYCN-amplified tumours, the post-treatment MYCN-amplified tumours displayed dramatic alterations in the genetic landscape, including changes to the number of copy number alterations, which correlated with macrophage infiltration, suggesting tumour evolution within the altering TME [45]. The gene discussed is MYCN; the disease is neoplasm.